Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
42,12 USD | -0,40% | -1,98% | +18,38% |
Attività
Numero di dipendenti: 290
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Therapeutics
100,0
%
| 5 | 100,0 % | 4 | 100,0 % | -15,28% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States and Australia
100,0
%
| 5 | 100,0 % | 4 | 100,0 % | -15,28% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Stephen Betz
FOU | Founder | 58 | 01/01/08 |
Scott Struthers
FOU | Founder | 62 | 01/01/08 |
Marc Wilson
DFI | Director of Finance/CFO | 45 | 01/01/18 |
Dana Pizzuti
CTO | Chief Tech/Sci/R&D Officer | 69 | 30/09/22 |
Matt McDowell
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jeff Knight
COO | Chief Operating Officer | 53 | 30/08/21 |
Chris Robillard
PRN | Corporate Officer/Principal | - | 21/03/22 |
Garlan Adams
LAW | General Counsel | - | 16/06/21 |
Michael Monahan
LAW | General Counsel | - | 01/06/18 |
Brian Russell
PRN | Corporate Officer/Principal | - | 01/03/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Wendell Wierenga
CHM | Chairman | 76 | 01/10/15 |
Matthew Fust
BRD | Director/Board Member | 59 | 01/02/18 |
Director/Board Member | 71 | 03/09/20 | |
Caren Deardorf
BRD | Director/Board Member | 59 | 11/03/22 |
Director/Board Member | 60 | 03/01/22 | |
Weston Nichols
BRD | Director/Board Member | 39 | 01/02/18 |
Scott Struthers
FOU | Founder | 62 | 01/01/08 |
Stephanie Okey
BRD | Director/Board Member | 64 | 15/07/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 78 744 364 | 74 939 799 ( 95,17 %) | 0 | 95,17 % |
Coordinate società
Crinetics Pharmaceuticals, Inc.
6055 Lusk Boulevard
92121, San Diego
+858 450 6464
http://www.crinetics.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+18,38% | 3,32 Mrd | |
+1,51% | 42,75 Mrd | |
+49,22% | 41,61 Mrd | |
+8,57% | 41,34 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione CRNX
- Società Crinetics Pharmaceuticals, Inc.